Transgene Stock OTC Markets
Stocks
TRGN.F
FR0005175080
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
13:41:16 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.8000 USD | -5.88% |
|
-.--% | -20.00% |
| 09-25 | Transgene provides update on its operations |  |
| 09-08 | Transgene Expands ProBioGen Partnership With Additional License | MT |
| Market Cap | 194M 217M 181M 164M 309M 20.96B 311M 2.17B 848M 10.66B 814M 796M 34.27B | P/E 2026 * |
-5.05x | P/E 2027 * | -3.21x |
|---|---|---|---|---|---|
| Enterprise Value | 124M 139M 116M 105M 199M 13.47B 200M 1.4B 545M 6.85B 523M 512M 22.03B | EV / Sales 2026 * |
17.3x | EV / Sales 2027 * | 25.8x |
| Free-Float |
19.11% | Yield 2026 * |
-
| Yield 2027 * | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| TNG | Real-time | |
CBOE
| TNGp | Real-time | |
|
OTC Markets
| TRGN.F | Delayed | |
|
Deutsche Boerse AG
| TGNA | Delayed | |
|
CBOE
| 0OCQ | Real-time | |
|
Börse Stuttgart
| TGNA | Delayed | |
|
Boerse Muenchen
| TGNA | Real-time |
Last Transcript: Transgene
| 1 day | -5.88% | ||
| 3 months | -5.88% | ||
| 6 months | -20.00% | ||
| Current year | -20.00% |
| Current year | 0.8 |  | 0.85 |
| 1 year | 0.8 | | 1.08 |
| 3 years | 0.7 | | 1.59 |
| 5 years | 0.01 | | 3.06 |
| 10 years | 0.01 | | 4.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Riva
CEO | Chief Executive Officer | 65 | 2023-05-31 |
Lucie Larguier
DFI | Director of Finance/CFO | - | 2024-03-26 |
Simone Steiner
CTO | Chief Tech/Sci/R&D Officer | - | 2025-04-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Benoît Habert
BRD | Director/Board Member | 61 | 2010-07-26 |
| Director/Board Member | 77 | 2013-06-18 | |
Alain Mérieux
BRD | Director/Board Member | 88 | 2006-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.88% | -.--% | - | - | 225M | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| +0.46% | -0.97% | +23.51% | +79.34% | 58.81B | |
| +0.17% | +0.35% | +6.85% | +34.55% | 48.45B | |
| +0.50% | -2.14% | +331.33% | +702.20% | 42.84B | |
| -0.72% | -3.99% | +28.50% | +29.94% | 42.79B | |
| +0.34% | -0.52% | +6.56% | +109.35% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -0.88% | +0.18% | +33.69% | +25.06% | 30.28B | |
| -0.50% | -3.10% | -10.19% | -14.35% | 24.05B | |
| Average | -0.26% | -0.25% | +53.20% | +123.66% | 43.81B | |
| Weighted average by Cap. | +0.77% | -0.50% | +56.17% | +130.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.2M 8.06M 6.72M 6.1M 11.49M 780M 11.58M 80.72M 31.54M 396M 30.25M 29.6M 1.27B | 7.2M 8.06M 6.72M 6.1M 11.49M 780M 11.58M 80.72M 31.54M 396M 30.25M 29.6M 1.27B |
| Net income | -38.2M -42.75M -35.64M -32.37M -60.97M -4.14B -61.42M -428M -167M -2.1B -161M -157M -6.76B | -61.6M -68.94M -57.47M -52.2M -98.32M -6.67B -99.05M -691M -270M -3.39B -259M -253M -10.9B |
| Net Debt | -69.2M -77.45M -64.56M -58.64M -110M -7.49B -111M -776M -303M -3.81B -291M -284M -12.25B | -7.7M -8.62M -7.18M -6.53M -12.29M -834M -12.38M -86.33M -33.73M -424M -32.35M -31.65M -1.36B |
Employees
152
Calendar
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7070EUR
Average target price
1.100EUR
Spread / Average Target
+55.59%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- TNG Stock
- TRGN.F Stock
Select your edition
All financial news and data tailored to specific country editions
